Intracerebral Hemorrhage
Intracerebral hemmorrage (ICH) is defined as actue, spontanious non disturbing extravasation of blood into the mind pranchyma which might also expand to the ventricular machine and the sub archaniod area. ICH is responsible for 10-15% of stroke cases in USA and upto 20-30% in Asian populace. World wide incidence is 10-20 instances per 10000 human beings. The occurrence doubles with each decade of life above 45 years. Hemorrhages are greater common in older adults, however they will additionally arise in children. Despite all advances in control and neurocritical care, ICH remains the least treatable shape of stroke and therefore includes the highest hazard of severe morbidity and mortality as compared to ischematic stroke or subarachnoid hemorrhage. ICH is maximum commonly caused by hypertension, arteriovenous malformations, or head trauma. Treatment specializes in stopping the bleeding, eliminating the blood clot (hematoma), and relieving the pressure on the brain
Related Conference of Intracerebral Hemorrhage
20th World Congress on Gastroenterology -Therapeutics & Hepatology
Intracerebral Hemorrhage Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Advanced GI Endoscopy Techniques - Gastroenterology Conference 2026 (France)
- Advances in Gastrointestinal Oncology - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in GERD Treatment - WORLD GASTROENTEROLOGY 2026 (Spain)
- Alcoholic Liver Disease Studies - Gastroenterology Conference 2026 (France)
- Alcoholic Liver Disease: Emerging Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Artificial Intelligence & Digital Health in GI - Gastroenterology Conference 2026 (France)
- Autoimmune Liver Disorders - Gastroenterology Conference 2026 (France)
- Bariatric Surgery & Obesity-Related GI Disorders - Gastroenterology Conference 2026 (France)
- Barrett’s Esophagus: Current Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Celiac Disease: Latest Treatment Options - WORLD GASTROENTEROLOGY 2026 (Spain)
- Cholangiocarcinoma Research - Gastroenterology Conference 2026 (France)
- Clinical Trials & Translational Research - Gastroenterology Conference 2026 (France)
- Digestive Health’s, Therapeutics & Diagnostics - Gastrosummit 2026 (UK)
- Emerging Therapies for Crohn's - WORLD GASTROENTEROLOGY 2026 (Spain)
- Endoscopic Ultrasound (EUS) & Advanced Imaging - Gastroenterology Conference 2026 (France)
- Endoscopists - Gastrosummit 2026 (UK)
- Endoscopy - Gastrosummit 2026 (UK)
- Esophageal Disorders: Current Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Gastroenterologists - Gastrosummit 2026 (UK)
- Gastroenterology - Gastrosummit 2026 (UK)
- Gastrointestinal - Gastrosummit 2026 (UK)
- Gastrointestinal Disorders: Clinical Updates - Gastroenterology Conference 2026 (France)
- Gastrointestinal Oncology - Gastroenterology Conference 2026 (France)
- Gastrointestinal Polyposis Syndromes - Gastroenterology Conference 2026 (France)
- Gastrointestinal Stromal Tumors: Novel Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Geriatric Gastroenterology & Liver Disorders - Gastroenterology Conference 2026 (France)
- GI Bleeding & Hemostasis Innovations - Gastroenterology Conference 2026 (France)
- GI Surgeons - Gastrosummit 2026 (UK)
- Global Health & Public Health Challenges in GI & Liver - Gastroenterology Conference 2026 (France)
- Gut Microbiome & Therapeutics - Gastroenterology Conference 2026 (France)
- Hepatic Encephalopathy: Modern Management Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatitis C Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatocellular Carcinoma & Liver Tumor Management - Gastroenterology Conference 2026 (France)
- Hepatocellular Carcinoma: Latest Approaches - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatologists - Gastrosummit 2026 (UK)
- Inflammatory Bowel Disease (IBD) - Gastrosummit 2026 (UK)
- Inflammatory Bowel Disease Research - Gastroenterology Conference 2026 (France)
- Innovations in IBD Management - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver Cirrhosis: New Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver Disease: Chronic and Acute Management - Gastroenterology Conference 2026 (France)
- Liver Disorders - Gastrosummit 2026 (UK)
- Liver Transplantation Innovations - Gastroenterology Conference 2026 (France)
- Microbiome - Gastrosummit 2026 (UK)
- Microbiome and Gastrointestinal Health - WORLD GASTROENTEROLOGY 2026 (Spain)
- Minimally Invasive Gastrointestinal Surgery - Gastroenterology Conference 2026 (France)
- NAFLD and NASH Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- New Approaches to Peptic Ulcer Disease - WORLD GASTROENTEROLOGY 2026 (Spain)
- Non-Alcoholic Fatty Liver Disease (NAFLD) & NASH - Gastroenterology Conference 2026 (France)
- Nutrition, Diet, and Lifestyle in GI & Liver Health - Gastroenterology Conference 2026 (France)
- Oncologists - Gastrosummit 2026 (UK)
- Oncologists - Gastrosummit 2026 (UK)
- Palliative Care & Quality of Life in GI & Liver Disorders - Gastroenterology Conference 2026 (France)
- Pancreatitis: Modern Therapeutic Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Pediatric and Adult Liver Metabolic Disorders - Gastroenterology Conference 2026 (France)
- Pediatric Gastroenterology & Hepatology - Gastroenterology Conference 2026 (France)
- Pharmacology & Novel Therapeutics - Gastroenterology Conference 2026 (France)
- Precision Medicine - Gastrosummit 2026 (UK)
- Precision Medicine & Biomarkers in Gastroenterology & Hepatology - Gastroenterology Conference 2026 (France)
- Public Health - Gastrosummit 2026 (UK)
- Rare GI & Liver Disorders - Gastroenterology Conference 2026 (France)
- Regenerative Medicine in Liver & GI Disorders - Gastroenterology Conference 2026 (France)
- Therapeutics for Biliary Diseases - WORLD GASTROENTEROLOGY 2026 (Spain)
- Ulcerative Colitis: Innovative Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Viral Hepatitis Research - Gastroenterology Conference 2026 (France)
- Viral Hepatitis: New Treatment Paradigms - WORLD GASTROENTEROLOGY 2026 (Spain)
